KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $1000.0.

  • CRISPR Therapeutics AG's Exchange Rate Effect rose 10114.94% to $1000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $95000.0, marking a year-over-year increase of 55238.1%. This contributed to the annual value of $95000.0 for FY2025, which is 55238.1% up from last year.
  • As of Q4 2025, CRISPR Therapeutics AG's Exchange Rate Effect stood at $1000.0, which was up 10114.94% from -$27000.0 recorded in Q3 2025.
  • CRISPR Therapeutics AG's Exchange Rate Effect's 5-year high stood at $115000.0 during Q4 2022, with a 5-year trough of -$100000.0 in Q3 2022.
  • In the last 5 years, CRISPR Therapeutics AG's Exchange Rate Effect had a median value of $2500.0 in 2021 and averaged $2800.0.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first tumbled by 146000.0% in 2022, then skyrocketed by 390000.0% in 2025.
  • Over the past 5 years, CRISPR Therapeutics AG's Exchange Rate Effect (Quarter) stood at $3000.0 in 2021, then skyrocketed by 3733.33% to $115000.0 in 2022, then tumbled by 46.96% to $61000.0 in 2023, then plummeted by 242.62% to -$87000.0 in 2024, then soared by 101.15% to $1000.0 in 2025.
  • Its last three reported values are $1000.0 in Q4 2025, -$27000.0 for Q3 2025, and $80000.0 during Q2 2025.